Zydus Lifesciences Ltd.

Cadila Healthcare has informed that a meeting of the Board of Directors of the Company will be held on February 07, 2014, inter alia, to consider & approve the unaudited financial results for the quarter/nine months ended on December 31, 2013. Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 1992, the Trading Window will remain close from January 29, 2014 to February 08, 2014 for all Directors and designated officers of the Company.

The above information is a part of company’s filings submitted to BSE